The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Cutting Edge: Functional Requirement for SAP in 2B4-Mediated Activation of Human Natural Killer Cells as Revealed by the X-Linked Lymphoproliferative Syndrome
Abstract
X-linked lymphoproliferative syndrome (XLP) is an immunodeficiency characterized by life-threatening infectious mononucleosis and EBV-induced B cell lymphoma. The gene mutated in XLP encodes SLAM (signaling lymphocytic activation molecule-associated protein)-associated protein (SAP), a small SH2 domain-containing protein. SAP associates with 2B4 and SLAM, activating receptors expressed by NK and T cells, and prevents recruitment of SH2 domain-containing protein tyrosine phosphatase-2 SHP-2) to the cytoplasmic domains of these receptors. The phenotype of XLP may therefore result from perturbed signaling through SAP-associating receptors. We have addressed the functional consequence of SAP deficiency on 2B4-mediated NK cell activation. Ligating 2B4 on normal human NK cells with anti-2B4 mAb or interaction with transfectants bearing the 2B4 ligand CD48 induced NK cell cytotoxicity. In contrast, ligation of 2B4 on NK cells from a SAP-deficient XLP patient failed to initiate cytotoxicity. Despite this, CD2 or CD16-induced cytotoxicity of SAP-deficient NK cells was similar to that of normal NK cells. Thus, selective impairment of 2B4-mediated NK cell activation may contribute to the immunopathology of XLP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Self-citationNoguchi, M. (1993) · Cell · doi:10.1016/0092-8674(93)90167-o · Cited by 1,320
Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, M. G., et al. (1998) · Nature · doi:10.1038/26683 · Cited by 943
REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 939
Coffey, A. J., Brooksbank, R. A., Brandau, O., Oohashi, T., Howell, G. R., Bye, J. M., Cahn, A. P., Durham, J., Heath, P., Wray, P., et al. (1998) · Nature Genetics · doi:10.1038/2424 · Cited by 754
Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome
Nichols, K. E., Harkin, D. P., Levitz, S., Krainer, M., Kolquist, K. A., Genovese, C., Bernard, A., Ferguson, M., Zuo, L., Snyder, E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13765 · Cited by 498
Self-citationZAP-70 Deficiency in an Autosomal Recessive form of Severe Combined Immunodeficiency
Chan, A. C., Kadlecek, T. A., Elder, M. E., Filipovich, A. H., Kuo, W.-L., Iwashima, M., Parslow, T. G., & Weiss, A. (1994) · Science · doi:10.1126/science.8202713 · Cited by 494
A novel receptor involved in T-cell activation
Cocks, B. G., Chang, C.-C. J., Carballido, J. M., Yssel, H., de Vries, J. E., & Aversa, G. (1995) · Nature · doi:10.1038/376260a0 · Cited by 479
X-Linked Lymphoproliferative Disease
Parolini, S., Bottino, C., Falco, M., Augugliaro, R., Giliani, S., Franceschini, R., Ochs, H. D., Wolf, H., Bonnefoy, J.-Y., Biassoni, R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.337 · Cited by 477
2B4, the Natural Killer and T Cell Immunoglobulin Superfamily Surface Protein, Is a Ligand for CD48
Brown, M. H., Boles, K., Anton van der Merwe, P., Kumar, V., Mathew, P. A., & Neil Barclay, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2083 · Cited by 415
Yssel, H., De Vries, J. E., Koken, M., Van Blitterswijk, W., & Spits, H. (1984) · Journal of Immunological Methods · doi:10.1016/0022-1759(84)90450-2 · Cited by 373
An Essential Role for BLNK in Human B Cell Development
Minegishi, Y., Rohrer, J., Coustan-Smith, E., Lederman, H. M., Pappu, R., Campana, D., Chan, A. C., & Conley, M. E. (1999) · Science · doi:10.1126/science.286.5446.1954 · Cited by 346
Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
Robertson, M. J., Cochran, K., Cameron, C. A., Le, J. M., Tantravahi, R. V., & Ritz, J. (1996) · PubMed · Cited by 343
Phillips, J. H., Gumperz, J. E., Parham, P., & Lanier, L. L. (1995) · Science · doi:10.1126/science.7716542 · Cited by 305
Self-citationTangye, S. G., Lazetic, S., Woollatt, E., Sutherland, G. R., Lanier, L. L., & Phillips, J. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.6981 · Cited by 297
Self-citationGarni-Wagner, B. A., Purohit, A., Mathew, P. A., Bennett, M., & Kumar, V (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.1.60 · Cited by 288
Activating interactions in human NK cell recognition: the role of 2B4-CD48
Nakajima, H., Cella, M., Langen, H., Friedlein, A., & Colonna, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199905)29:05<1676::aid-immu1676>3.0.co;2-y · Cited by 242
Poy, F., Yaffe, M. B., Sayos, J., Saxena, K., Morra, M., Sumegi, J., Cantley, L. C., Terhorst, C., & Eck, M. J. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80206-3 · Cited by 241
Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes.
Valiante, N. M., & Trinchieri, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1397 · Cited by 223
Mathew, P. A., Garni-Wagner, B. A., Land, K., Takashima, A., Stoneman, E., Bennett, M., & Kumar, V (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.10.5328 · Cited by 202
Nakajima, H., Cella, M., Bouchon, A., Grierson, H. L., Lewis, J., Duckett, C. S., Cohen, J. I., & Colonna, M. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200011)30:11<3309::aid-immu3309>3.0.co;2-3 · Cited by 170
Aversa, G., Chang, C., Carballido, J. M., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4036 · Cited by 165
Castro, A. G., Hauser, T. M., Cocks, B. G., Abrams, J. S., Zurawski, S., Churakova, T., Zonin, F., Robinson, D. S., Tangye, S. G., Aversa, G., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.5860 · Cited by 138
Self-citationTangye, S. G., Phillips, J. H., & Lanier, L. L. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0217 · Cited by 136
Self-citationProtein tyrosine phosphatases in T-cell development, apoptosis and signalling
Frearson, J. A., & Alexander, D. R. (1996) · Immunology Today · doi:10.1016/0167-5699(96)10026-8 · Cited by 107
Conley, M. E., Parolini, O., Rohrer, J., & Campana, D. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00844.x · Cited by 80
The biology of Epstein-Barr virus: lessons learned from the virus and the host
Cohen, J. I. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80062-4 · Cited by 58
Cited by
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
Self-citationUp on the tightrope: natural killer cell activation and inhibition
Lanier, L. L. (2008) · Nature Immunology · doi:10.1038/ni1581 · Cited by 1,656
Self-citationNatural killer cells, viruses and cancer
Cerwenka, A., & Lanier, L. L. (2001) · Nature Reviews Immunology · doi:10.1038/35095564 · Cited by 875
Self-citationNew aspects of natural-killer-cell surveillance and therapy of cancer
Smyth, M. J., Hayakawa, Y., Takeda, K., & Yagita, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc928 · Cited by 752
Chtanova, T., Tangye, S. G., Newton, R., Frank, N., Hodge, M. R., Rolph, M. S., & Mackay, C. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.68 · Cited by 722
Self-citation
Metadata
- Authors
- Tangye, S. G., Phillips, J. H., Lanier, L. L., & Nichols, K. E.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-09
- Volume
- 165
- Issue
- 6
- Pages
- 2932-2936
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2157588893
- Cited by
- 265
- References
- 27
- FWCI
- 8.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.